✦ LIBER ✦

Randomized, Double-Blind, Crossover Trial of Sildenafil in Men With Mild to Moderate Erectile Dysfunction: Efficacy at 8 and 12 Hours Postdose

✍ Scribed by Andrew R. McCullough; Christopher P. Steidle; Brian Klee; Li-Jung Tseng

Book ID: 116949068
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 382 KB
Volume: 71
Category: Article
ISSN: 0090-4295
DOI: 10.1016/j.urology.2007.12.025

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomized, Double-Blind, Crossover Tria

Randomized, Double-Blind, Crossover Trial of Sildenafil in Men With Mild to Moderate Erectile Dysfunction: Efficacy at 8 and 12 Hours Postdose

✍ Shindel, A. 📂 Article 📅 2009 🏛 Elsevier Science ⚖ 48 KB

ERECTILE FUNCTION AND ERECTION HARDNESS

ERECTILE FUNCTION AND ERECTION HARDNESS AT INTERCOURSE ATTEMPTS 8 HOURS POSTDOSE IN MEN WITH MILD TO MODERATE ERECTILE DYSFUNCTION RECEIVING SILDENAFIL CITRATE 100 MG

✍ Kaufman, Joel M; McCullough, Andrew R; Steidle, Christopher P; Goldfischer, Evan 📂 Article 📅 2008 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 212 KB

A phase II, single-blind, randomized, cr

A phase II, single-blind, randomized, crossover evaluation of the safety and efficacy of avanafil using visual sexual stimulation in patients with mild to moderate erectile dysfunction

✍ Wayne J.G. Hellstrom; Matthew T. Freier; Ege Can Serefoglu; Ronald W. Lewis; Kar 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 399 KB

Comparison of efficacy and tolerability

Comparison of efficacy and tolerability of amlodipine orotate versus amlodipine besylate in adult patients with mild to moderate hypertension: A multicenter, randomized, double-blind, placebo-controlled, parallel-group, 8-week follow-up noninferiority trial

📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 37 KB

Efficacy and safety profiles of a new S(

Efficacy and safety profiles of a new S(—)-amlodipine nicotinate formulation versus racemic amlodipine besylate in adult Korean patients with mild to moderate hypertension: An 8-week, multicenter, randomized, double-blind, double-dummy, parallel-group, phase III, noninferiority clinical trial

✍ Sung Ai Kim; Sungha Park; Namsik Chung; Do-Sun Lim; Joo-Young Yang; Byung-Hee Oh 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 203 KB

Efficacy and Tolerability of Fimasartan,

Efficacy and Tolerability of Fimasartan, a New Angiotensin Receptor Blocker, Compared With Losartan (50/100 mg): A 12-Week, Phase III, Multicenter, Prospective, Randomized, Double-Blind, Parallel-Group, Dose Escalation Clinical Trial With an Optional 12-Week Extension Phase in Adult Korean Patients With Mild-to-Moderate Hypertension

✍ Sang Eun Lee; Yong-Jin Kim; Hae-Young Lee; Han-Mo Yang; Chang-Gyu Park; Jae-Joon 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 806 KB